跳至主要内容
临床试验/IRCT20090822002365N21
IRCT20090822002365N21招募中3 期

The effect of saffron supplement on Antioxidative Status and Activity illness in patients with Ulcerative colitis

Iran University of Medical Sciences0 个研究点目标入组 96 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
96

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • The willingness to voluntarily participate in the study
  • The diagnosis of ulcerative colitis in the mild to moderate phase by the physician
  • The consumer of only one of the drug groups 5 -Amino salicylic acid (Pentasa, Mesalazine or Asacol), as well as azathioprine
  • BMI greater than 18.5 and less than 30

排除标准

  • Changing the type and dosage of the drug over the past month
  • The incidence of other autoimmune diseases, cancer
  • The use of multi vitamin-mineral supplements, antioxidants, and also the use of anticoagulants, blood cholesterol lowering drugs, anti-TNF drugs, and glucocorticosteroids over the past month
  • Pregnancy or lactation in women
  • Non-compliance with treatment (less than 80%)

研究者

相似试验

The effect of saffron supplement on patients with... | 临床试验